← Back to home

MOBILIZATION OF HEMATOPOIETIC STEM CELLS (HSC) TO PERIPHERAL BLOOD (PB)

Clinical trials for MOBILIZATION OF HEMATOPOIETIC STEM CELLS (HSC) TO PERIPHERAL BLOOD (PB) explained in plain language.

Never miss a new study

Get alerted when new MOBILIZATION OF HEMATOPOIETIC STEM CELLS (HSC) TO PERIPHERAL BLOOD (PB) trials appear

Sign up with your email to follow new studies for MOBILIZATION OF HEMATOPOIETIC STEM CELLS (HSC) TO PERIPHERAL BLOOD (PB), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Faster blood recovery after cancer transplant? new drug combo shows promise

Disease control Recruiting now

This study is testing whether adding a drug called IL-11 to the standard drug G-CSF helps patients' blood cells recover more quickly after a stem cell transplant for blood cancers like multiple myeloma or lymphoma. The goal is to shorten the time patients have low platelet and re…

Matched conditions: MOBILIZATION OF HEMATOPOIETIC STEM CELLS (HSC) TO PERIPHERAL BLOOD (PB)

Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control

Last updated Mar 30, 2026 14:29 UTC

MOBILIZATION OF HEMATOPOIETIC STEM CELLS (HSC) TO PERIPHERAL BLOOD (PB)

Get alerted when new MOBILIZATION OF HEMATOPOIETIC STEM CELLS (HSC) TO PERIPHERAL BLOOD (PB) trials appear

Faster blood recovery after cancer transplant? new drug combo shows promise